Navigation Links
Mentice, Inc. Expands Its North American Sales and Clinical Presence With the Hiring of Jeff Sirek as Director of Educational Sales-East and Sue Landsman as Clinical Applications Manager for the Americas.
Date:4/25/2008

EVANSTON, Ill., April 25 /PRNewswire/ -- Mentice, Inc., (a wholly owned subsidiary of Mentice AB), a leading supplier of virtual reality based training applications within the field of medicine, has recently appointed Jeff Sirek Director of Educational Sales-East and Sue Landsman as Clinical Applications Manager for the Americas.

Jeff Sirek joins Mentice after five top performing and highly successful years with GE Healthcare in its Cardiovascular Ultrasound Division as Regional Sales Manager for the Northeastern US. Prior to his experience at GE Healthcare, Mr. Sirek was Vice-President of North American Sales at Color Kinetics, Inc. where he was responsible for building the sales team and driving exponential revenue growth, which ultimately led to its acquisition by Philips. Mr. Sirek held previous sales roles at Adac Laboratories, Sopha Medical Systems and Pfizer, Inc.

Mr. Sirek will be tasked with driving the educational/hospital market for medical simulation for the eastern half of the US.

Sue Landsman brings to Mentice a wealth of experience in a broad range of endovascular areas after spending many successful years in a variety of clinical and sales management roles with the following companies: Boston Scientific Corp., Heart Technology, Inc., St. Jude Medical, Johnson & Johnson, Jomed, Inc. and Volcano Corporation.

Ms. Landsman will lead the development and implementation of clinical programs designed to drive the continued acceptance and usage of medical simulation systems within the educational/hospital and industry markets.

"The hiring of Mr. Sirek and Ms. Landsman illustrates Mentice's commitment to the North American market for medical simulation. Mentice has recently redirected its efforts to provide consultancy services to teaching institutions and its industry clients in concert with the successful implementation of its many simulation products. Mr. Sirek and Ms. Landsman will play a vital role in this strategic and exciting objective," said Tim Shannon, VP of Sales and Marketing -- Americas.

About Mentice:

Mentice is a leader in medical simulation with approximately 600 installations worldwide and 100 validation studies. Mentice's Family of Procedicus (TM) simulators focus on the area of minimally invasive surgery within the fields of endovascular intervention, core skills training, laparoscopy and arthroscopy training.

Website info: http://www.mentice.com

For more information contact:

Tim Shannon, Mentice Inc. U.S. office

1-877-MENTICE or email usinfo@mentice.com or tim.shannon@mentice.com

Release#42508


'/>"/>
SOURCE Mentice, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Mentice, Inc. Announces Appointment of Vice-President, Sales and Marketing, Americas
2. Longaberger Expands Horizon of Hope Campaign to Build Support for American Cancer Societys Breast Cancer Initiatives
3. Rohm and Haas Expands in India
4. Concentra Expands Horizon Air Employee Health Program With On-Site Clinic
5. Regional Center of Orange County Expands Family Support Resources to Meet Growing Needs
6. Maimonides Expands Circulation of Physicians Practice Journal to Staten Island Doctors
7. Specialty Blades, Inc. Expands Management Team With New VP Engineering
8. CRH Medical expands Las Vegas operations
9. US Med-Equip Expands Corporate Support Center
10. ISTA Pharmaceuticals Expands Its Pipeline in Allergy Treatments
11. Bipartisan Bill Expands Health Care Access for Small Businesses
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... ... February 27, 2017 , ... ... last week. In addition, Discount Power's RCE (Residential Customer Equivalent) count exceeds ... 2014. The company had 800 customers and 2,250 RCEs at the time of ...
(Date:2/26/2017)... ... February 25, 2017 , ... The February 13, 2017, assassination of Kim ... over nerve agents and the deadly use of chemical weapons. Many questions exist about ... even small doses can be lethal. , Jay Jagannathan, M.D., of Michigan-based Jagannathan Neurosurgical ...
(Date:2/26/2017)... ... February 26, 2017 , ... IndustryArchive.Org . is announcing a new ... B2B Sellers will now only pay for B.A.N.T. quality sales leads based on the ... said, “Given the new reality that B2B buyers are controlling the sales process via ...
(Date:2/25/2017)... Viejo, CA (PRWEB) , ... February 25, 2017 , ... ... with ProSharpen Color tools from Pixel Film Studios. With ProSharpen Color users have total ... sliders to easily refine their color range. With color spectrum tools users can visually ...
(Date:2/24/2017)... ... February 24, 2017 , ... An in-depth computational analysis of genetic variants implicated ... to eight genes that may explain why susceptibility to one of the disorders could ... study published today in the journal npj Schizophrenia. , “There is a wealth ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)...  International Biophysics Corporation, a global medical device manufacturer based ... 34% revenue growth in 2016 when compared to the previous ... growth was fueled by its AffloVest® sales in ... of its global sales of surgical product lines. ... enter our 25 th year in delivering high-quality, innovative ...
(Date:2/27/2017)... , Feb. 27, 2017  RegeneRx Biopharmaceuticals, ... clinical-stage drug development company focused on tissue protection, ... for RGN-137, GtreeBNT Co., Ltd., received a positive ... 3 clinical trial design for RGN-137 to treat ... healing gel that incorporates Thymosin beta 4 ("Tß4") ...
(Date:2/27/2017)... Leading Countries, Technologies and Companies The global ... CAGR of 8.9% from 2016-2021 and CAGR of 9.2% from 2021-2027. ... from 2016 to 2027. The market is estimated at $816m in ... ... to discover how you can exploit the future business opportunities emerging ...
Breaking Medicine Technology: